First Quadrant’s Ultralife ULBI Stock Holding History

First Quadrant’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,733	Closed	-$11K	–	617
2020 Q4	$11K	Buy	+1,733	New	+$10.9K	﹤0.01%	564

Other funds holding ULBI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Quadrant's ULBI Position: Q1 2021 in Review

First Quadrant sold out of Ultralife (ULBI) in Q1 2021, closing a stake of 1,733 shares — an estimated $11K sold.

First Quadrant first reported a position in ULBI in Q4 2020 and held it in 1 quarter. The position peaked at $11K in Q4 2020. 55 funds tracked by Wall St. Rank hold ULBI as of Q1 2021.

First Quadrant reported no remaining Ultralife position as of Q1 2021 after selling out during the quarter.
First Quadrant sold 1,733 Ultralife shares in Q1 2021, an estimated $11K.
First Quadrant first reported a position in Ultralife in Q4 2020 and held it in 1 quarter.
First Quadrant's Ultralife position peaked at $11K in Q4 2020.
55 funds tracked by Wall St. Rank held Ultralife as of Q1 2021.

Based on First Quadrant's 13F filing for Q1 2021, filed 27 Apr 2021.